Senior insider sale
General Counsel at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$870.9K
42.04K shares
HANSON KRISTOPHER plans to sell 42.04K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $870.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/26/2025 | Restricted Stock Unit Grant N/A | 6.77K | — |
7/18/2025 | Restricted Stock Unit Grant N/A | 5.89K | — |
5/2/2024 | Restricted Stock Unit Grant N/A | 3.01K | — |
11/9/2023 | Restricted Stock Unit Grant N/A | 852.00 | — |
7/30/2023 | Restricted Stock Unit Grant N/A | 1.67K | — |
| Total | 18.20K | ||
Completed
Units to sell
16.51K
Market value
$192.6K
Units to sell
1.13K
Market value
$42.8K
Units to sell
8.12K
Market value
$298.6K
Units to sell
7.26K
Market value
$266.3K
Planned — Approximate Date
Units to sell
9.02K
Market value
$70.4K
Units
42.04K
Value
$870.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/16/2026 | 16.51K | $192.6K | — | Completed |
7/17/2026 | 1.13K | $42.8K | — | Completed |
7/16/2026 | 8.12K | $298.6K | — | Completed |
7/15/2026 | 7.26K | $266.3K | — | Completed |
| Planned — Approximate Date | ||||
10/15/2026 | 9.02K | $70.4K | NASDAQ | Planned |
| Total | 42.04K | $870.9K | ||